Comparison and Analysis between the NAV6 Embolic Protection Filter and SpiderFX EPD Filter in Superficial Femoral Artery Lesions
Table 1
Demographics and risk factors.
% (n/N)
Emboshield NAV6 (N = 161)
SpiderFX EPD (N = 346)
value
Gender (female)
46.3% (75/161)
43.6% (151/346)
0.575
Age (years)a
69.8 ± 10.3 (161)
68.8 ± 10.8 (346)
0.844
BMI (kg/m2)a
27.3 ± 5.0 (161)
28.2 ± 5.7 (346)
0.416
Diabetes mellitus
59.3% (96/161)
61.8% (214/346)
0.577
Smoking
45.1% (73/161)
53.2% (184/346)
0.088
Hyperlipidemia
97.5% (158/161)
87.0% (301/346)
<0.05
Hypertension
98.1% (159/161)
94.8% (328/346)
0.077
Coronary artery disease
83.3% (135/161)
83.8% (290/346)
0.891
Chronic kidney disease
3.1% (5/161)
1.4% (5/346)
0.215
aValues in mean ± SD. bBy normal approximation for continuous variables and the Newcombe score method for binary variables. BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SD, standard deviation.
